Equities Analysts Issue Forecasts for Premier, Inc.’s Q1 2025 Earnings (NASDAQ:PINC)

Premier, Inc. (NASDAQ:PINC) – Analysts at Leerink Partnrs dropped their Q1 2025 EPS estimates for shares of Premier in a research report issued on Wednesday, August 21st. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $0.19 per share for the quarter, down from their prior estimate of $0.47. The consensus estimate for Premier’s current full-year earnings is $1.96 per share. Leerink Partnrs also issued estimates for Premier’s Q2 2025 earnings at $0.23 EPS, FY2026 earnings at $1.03 EPS, FY2027 earnings at $1.06 EPS and FY2028 earnings at $1.13 EPS.

Premier (NASDAQ:PINC) last released its quarterly earnings results on Tuesday, August 20th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.25. Premier had a net margin of 6.01% and a return on equity of 11.71%. The firm had revenue of $350.30 million for the quarter, compared to analysts’ expectations of $308.88 million. During the same quarter in the prior year, the firm posted $0.70 earnings per share. The business’s quarterly revenue was up 2.9% on a year-over-year basis.

PINC has been the subject of several other research reports. Canaccord Genuity Group lowered Premier from a “buy” rating to a “hold” rating and cut their price objective for the stock from $27.00 to $21.00 in a report on Wednesday, May 8th. Canaccord Genuity Group decreased their price target on shares of Premier from $21.00 to $20.00 and set a “hold” rating on the stock in a report on Wednesday, August 21st. JPMorgan Chase & Co. dropped their price objective on shares of Premier from $23.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, May 28th. Robert W. Baird reduced their target price on Premier from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 21st. Finally, Piper Sandler dropped their price target on Premier from $24.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Eight investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Premier presently has an average rating of “Hold” and an average price target of $22.19.

Premier Price Performance

Shares of NASDAQ PINC opened at $20.50 on Monday. The stock’s 50-day simple moving average is $19.41 and its two-hundred day simple moving average is $20.16. Premier has a twelve month low of $17.95 and a twelve month high of $24.27. The firm has a market capitalization of $2.15 billion, a P/E ratio of 32.03, a P/E/G ratio of 6.62 and a beta of 0.42. The company has a quick ratio of 0.82, a current ratio of 0.93 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On Premier

Hedge funds and other institutional investors have recently made changes to their positions in the business. Mitsubishi UFJ Trust & Banking Corp bought a new stake in Premier in the first quarter valued at $27,000. Hexagon Capital Partners LLC lifted its position in shares of Premier by 71.7% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,660 shares of the company’s stock worth $37,000 after purchasing an additional 693 shares during the period. Versant Capital Management Inc lifted its position in shares of Premier by 265.2% in the 2nd quarter. Versant Capital Management Inc now owns 2,140 shares of the company’s stock worth $40,000 after purchasing an additional 1,554 shares during the period. Abich Financial Wealth Management LLC boosted its stake in shares of Premier by 50.0% during the 1st quarter. Abich Financial Wealth Management LLC now owns 1,951 shares of the company’s stock valued at $43,000 after purchasing an additional 650 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in shares of Premier by 141.2% during the fourth quarter. Parallel Advisors LLC now owns 1,980 shares of the company’s stock valued at $44,000 after buying an additional 1,159 shares during the period. Institutional investors own 74.41% of the company’s stock.

Insider Activity at Premier

In other news, insider Andy Brailo sold 13,318 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $19.00, for a total value of $253,042.00. Following the transaction, the insider now owns 98,427 shares in the company, valued at $1,870,113. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Andy Brailo sold 13,318 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $19.00, for a total transaction of $253,042.00. Following the completion of the sale, the insider now directly owns 98,427 shares in the company, valued at $1,870,113. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael J. Alkire sold 2,625 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $20.00, for a total value of $52,500.00. Following the completion of the sale, the chief executive officer now directly owns 580,073 shares in the company, valued at $11,601,460. The disclosure for this sale can be found here. Insiders sold 125,428 shares of company stock worth $2,471,783 in the last ninety days. 0.85% of the stock is owned by company insiders.

Premier Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, September 15th. Stockholders of record on Sunday, September 1st will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.10%. The ex-dividend date of this dividend is Friday, August 30th. Premier’s dividend payout ratio (DPR) is presently 131.25%.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.